Are There Benefits in Adding Catechol-O Methyltransferase Inhibitors in the Pharmacotherapy of Parkinson’s Disease Patients? A Systematic Review

Irene Katsaiti, John Nixon
  • Journal of Parkinson s Disease, June 2018, IOS Press
  • DOI: 10.3233/jpd-171225

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.3233/jpd-171225

In partnership with: